Management Q&A. ASM offers 'enhanced precautions for handling specimens from suspected Ebola patients.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Works matching IS 05807247 AND DT 2015 AND VI 47 AND IP 1
Results: 16
1
2
Sunquest guides clients to make informed, innovative laboratory software choices... Matt Hawkins.
- Published in:
- 2015
- By:
- Publication type:
- Interview
3
Product focus.
- Published in:
- 2015
- Publication type:
- Product Review
4
Liability and the Lab. U.S. transport labels: two changes to know about.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 32
- By:
- Publication type:
- Article
5
Management Q&A. ASM offers "enhanced precautions for handling specimens from suspected Ebola patients.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 30
- By:
- Publication type:
- Article
6
Achieving excellent drugs-of-abuse analysis starts with the proper sample preparation technique.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 28
- By:
- Publication type:
- Article
7
Drugs of abuse: a challenging landscape for laboratories.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 26
- By:
- Publication type:
- Article
8
Molecular monitoring for minimal residual disease.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 24
- By:
- Publication type:
- Article
9
Quality control in clinical laboratory samples.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 22
- By:
- Publication type:
- Article
10
IQCP and more: whats on the horizon for 2015?
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 18
- By:
- Publication type:
- Article
11
Determining myocardial infarction after PCI: CK-MB, troponin, both, or neither?
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 14
- By:
- Publication type:
- Article
12
Predictability of urinalysis parameters in the diagnosis of urinary tract infection: a case study.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 8
- By:
- Publication type:
- Article
13
The Observatory. Drugs of Abuse.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 6
- Publication type:
- Article
14
The Observatory. Cancer.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 6
- Publication type:
- Article
15
The Observatory. Ebola.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 6
- Publication type:
- Article
16
From the editor. Clinical lab community mobilizes against increased FDA regulation of LDTs.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 1, p. 4
- By:
- Publication type:
- Article